Innovating Epilepsy Treatment: How PRECISIS is Transforming Healthcare Startups
Meet the biotech startup from Heidelberg with US CEO Karl.
In the rapidly evolving world of healthcare technology, PRECISIS, a Heidelberg-based startup, is making waves by addressing the critical unmet needs of epilepsy patients. With its groundbreaking EASI System, PRECISIS is revolutionizing the treatment of drug-resistant epilepsy, setting a new standard in neuromodulation.
If you’re a startup founder, healthcare entrepreneur, or investor, this article offers invaluable insights into how PRECISIS is blending innovation and impact to transform lives while creating a scalable and sustainable business model.
What is PRECISIS?
Founded in Heidelberg, Germany, PRECISIS is a healthcare startup at the forefront of epilepsy treatment innovation. The company’s flagship product, the EASI System, is the world’s first minimally invasive brain pacemaker, designed to reduce seizures in patients with drug-resistant focal epilepsy.
The Epilepsy Challenge
Epilepsy affects nearly 50 million people worldwide, and approximately 30% of those are classified as drug-resistant, meaning conventional medications fail to control their seizures. This represents a significant global health challenge—and an opportunity for innovation.
The impact of drug-resistant epilepsy goes beyond physical symptoms. Patients often face social isolation, difficulty maintaining employment, and a drastically reduced quality of life. PRECISIS addresses these challenges head-on with its pioneering technology.
The Revolutionary EASI System
The EASI System uses epicranial electrodes to deliver precise electrical stimulation to specific brain regions, reducing seizure frequency by at least 50% for most patients.
Key Features:
Minimally Invasive Design: The EASI System eliminates the need for invasive brain surgery, offering a safer, less disruptive alternative.
Manual Stimulation: Patients can activate additional stimulation if they sense an oncoming seizure, empowering them to take control of their condition.
MRI Compatibility: Unlike many neuromodulation devices, the EASI System is fully compatible with MRI diagnostics, ensuring long-term usability.
Benefits for Patients:
Significant reduction in seizure frequency
Enhanced independence and quality of life
Minimal recovery time compared to traditional surgical interventions
Leadership That Inspires
At the helm of PRECISIS is Karl Stoklosa, a seasoned leader with over 20 years of experience in the medical device industry. Karl has held global roles at companies like Guidance and St. Jude Medical, specializing in cardiac rhythm management and neuromodulation.
His vision for PRECISIS combines technical expertise with a deep commitment to improving patient outcomes. For investors, Karl’s leadership underscores the company’s potential for sustained innovation and market success.
European Market Success and U.S. Expansion
PRECISIS achieved European market approval in 2022, rapidly scaling its operations in key markets like Germany, Austria, Switzerland, the UK, and Portugal. The company is now preparing for its U.S. market entry, having secured FDA breakthrough designation and planning its first randomized controlled clinical trials in North America.
For investors and partners, PRECISIS represents a unique opportunity to support a proven, high-impact technology poised for global growth.
Investment and Growth Opportunities
PRECISIS is actively seeking partnerships with venture capital firms, corporate partners, and angel investors to fund its next stage of growth. With a proven track record in Europe, the company is well-positioned to capture market share in the United States and beyond.
Call to Action: Join the Conversation
Love what you’ve learned about PRECISIS? Here’s how you can engage:
Subscribe to Startuprad.io: Stay informed about the latest innovations in healthcare startups.
Share Your Thoughts: Join the conversation by leaving a comment or sharing this article.
Explore Opportunities: Learn how to partner with PRECISIS or similar startups shaping the future of healthcare.
Links to Explore:
Original Blog Post: https://www.startuprad.io/blog/innovating-epilepsy-treatment-with-precisis-a-healthcare-startup-revolutionizing-technology
Work With Us: https://www.startuprad.io/become-a-partner
Subscribe: https://linktr.ee/startupradio
Give Feedback: https://forms.gle/SrcGUpycu26fvMFE9
Follow the Editor-in-Chief: http://www.linkedin.com/comm/mynetwork/discovery-see-all?usecase=PEOPLE_FOLLOWS&followMember=joernmenninger
Special Offer for Startuprad.io Listeners:
Create two free SEO-optimized blog posts per month with https://moderniqs.com/create-an-account/?res_aff=startupradio. Don’t miss this exclusive deal—sign up now!